Generic placeholder image

Coronaviruses

Editor-in-Chief

ISSN (Print): 2666-7967
ISSN (Online): 2666-7975

Perspective Article

Understanding the Role of HDL during COVID-19 Infection

Author(s): Iti Garg*, Swati Srivastava* and Bhuvnesh Kumar

Volume 2, Issue 3, 2021

Published on: 18 September, 2020

Page: [289 - 290] Pages: 2

DOI: 10.2174/2666796701999200918160757

Abstract

Background: Recently emerged COVID-19 pandemic has caused a large number of deaths with lacs of confirmed cases worldwide posturing a grim situation and severe threat to public health. There is an imperative necessity of analyzing emerging clinical and laboratory data of COVID-19 patients, which may contribute to elucidate the pathogenic mechanism and development of effective prevention and treatment countermeasures.

Methods: Under this article, the emerging role of High-Density Lipoprotein (HDL) was analyzed by collecting recently published articles related to this field having clinical data of COVID-19 patients.

Results: Based on the recently published reports of laboratory-confirmed COVID-19 infected hospitalized patients it was consistently observed that levels of HDL were low at the time of admission to hospital and remained relatively low during the disease course i.e., treatment, recovery, and discharge stage. It was also reported critically that levels of HDL in the patients, those did not survive, decreased continuously until death.

Conclusion: These clinical reports of patients have risen the concern about probable infection and worsen the clinical outcome of a healthy person having a compromised level of HDL for COVID-19 infection. Eventually, these findings stated that there is a strong association of low HDL levels with a higher risk of COVID-19 infection and further severity of the illness. Proper attention is needed to understand the significance of altered quantity and quality of HDL in COVID-19 patients compared to healthy controls, so that appropriate therapies could be given at the right time to combat severity and mortality due to this infection.

Keywords: Cholesterol, COVID-19, high density lipoprotein (HDL), risk, pathologies, infection

[1]
Pirillo A, Catapano AL, Norata GD. HDL in infectious diseases and sepsis High Density Lipoproteins. Handbook of Experimental PharmacologyCham: Springer 2015; p. 224.
[http://dx.doi.org/10.1007/978-3-319-09665-0_15]
[2]
Fan J, Wang H, Ye G, et al. Letter to the editor: Low-density lipoprotein is a potential predictor of poor prognosis in patients with coronavirus disease 2019. Metabolism. 2020; 107 154243 In:
[3]
Nie S, Zhao X, Zhao K, et al. Metabolic disturbances and inflammatory dysfunction predict severity of coronavirus disease 2019 (COVID-19): a retrospective study. MedRxiv 2020; 2020: 1.
[http://dx.doi.org/10.1101/2020.03.24.20042283]
[4]
Yang S, Shi Y, Lu H, et al. Clinical and CT features of early stage patients with COVID-19: a retrospective analysis of imported cases in Shanghai, China. Eur Respir J 2020; 55(4)2000407
[http://dx.doi.org/10.1183/13993003.00407-2020] [PMID: 32217649 PMCID: PMC7098483.]]
[5]
Hu X, Chen D, Wu L, He G, Ye W. Low serum cholesterol level among patients with COVID-19 infection in Wenzhou, China 2020. Lancet 2020; 2020: 1.
[http://dx.doi.org/10.2139/ssrn.3544826]

© 2022 Bentham Science Publishers | Privacy Policy